Stay updated with breaking news from Mark Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn't worked as well for solid tumors.
A new vaccine boosts the response of engineered CAR-T cells and helps the immune system generate T cells that target other tumor antigens. The researchers found this approach made it more likely that a tumor can be eradicated in mice.
Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of hepatocellular carcinoma. This is a proof of concept that lays the foundations for the application of this treatment in patients with the most common liver cancer.
Luxembourg-based ABH Holdings S.A. ("ABHH"), co-owned by Russian oligarch Mikhail Fridman, will seek to protect its investments via legal action if JSC Sense Bank (owned by ABHH) is nationalized, according to an official press release dated June 16.
A change of scenery can restore one's outlook, but for some precancerous cells, a journey from the caves of the bone marrow to the sunny climes of the skin can trigger genetic changes that are a harbinger of cancer, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Broad Institute of MIT and Harvard.